ANDA 219991, held by Fresenius Kabi USA. Ephedrine Sulfate.
As of Nov 16, 2026, ANDA 219991 (Ephedrine Sulfate), held by Fresenius Kabi USA, was first approved by FDA on Mar 19, 2026, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 19, 2026 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Ephedrine Sulfate50MG/10ML (5MG/ML) ยท solution;intravenous | Ephedrine Sulfate | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters